Growth on track, margin pressure evident; capex ramp ahead
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Reaffirmed India mid-to-high teens and consol 10-12% guidance; +16.3% YoY delivery aligns. Advantek PAT timing slipped.
Cautiously Optimistic
next 1–2 quarters
Very Optimistic
multi-year
Q2 growth +16.3% YoY validates mid-to-high teens India guidance, but OPM 17% vs 20-22% target and Romania ₹10-12 Cr losses FY27 compress near-term PAT. Long-term very optimistic (30% Bushing/Stamping growth, INR75 Cr resourcing, INR150+ Cr capex expansion with renewable/windmill tailwinds), but 12-15 month capex execution and metal price volatility are near-term headwinds.
₹440.1 Cr
Revenue · +16.3% YoY₹45 Cr
Reported PAT · +23.6% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Strong 24% H1 line growth
OVERSTATEDH1 consolidated revenue growth (implied) ~16-17% based on YoY; India segment higher per mgmt
India high-teens growth FY27
METQ2 YoY +16.3% consol; India portion claimed ~22% H1 YoY by CFO
Margin 20-22% sustainable at longer horizon
MISSQ2 OPM 17.0%, NPM 10.1%; India Engineering EBITDA 23.7% but dragged by Solar 9% revenue, Romania losses
Bushing/Stamping each 30% growth FY27
UnverifiedNot visible in Q2 consolidated numbers; claimed as forward-looking; no breakout given this quarter
Advantek on track, PAT positive FY27
OVERSTATEDAdvantek guidance ₹140 Cr reaffirmed but Q1 losses ~₹7 Cr; H2 expected to improve, not yet positive
Earnings quality
What changed since the last call
Advantek PAT timing deferred
DowngradePrior call promised FY27 PAT positive; now saying H2 improvement, Q1 showed ₹7 Cr loss. Full-year PAT still expected positive per Q&A, but near-term drag acknowledged.
Romania loss quantum flagged
DowngradeWas vague prior call; now management saying FY27 loss will be 'much lower' but didn't quantify. Analyst extrapolated ₹10-12 Cr from context (vs ₹14 Cr FY26).
Capex acceleration committed
UpgradePrior guidance ₹50-80 Cr FY27; now managing 12-15 month timeline for INR220 Cr Advantek+China phases. Incremental borrowing approved per CFO; front-loading capex spend.
India growth pace reaffirmed
NeutralStill mid-to-high teens; +22% H1 YoY (India segment) claimed vs prior 'high-teens' target. On track but not raised.
Consol guidance maintained at 10-12%
NeutralNo change from Q1 call; current +16.3% consol YoY is ABOVE this range, but mgmt cautious on H2 seasonality, Romania, China softness.
The Q&A
Analysts pressed hard on Romania losses (deferred), Advantek capex breakup (eventually clarified), Stamping margin dilution (acknowledged but not detailed), China growth (defended 5-7% forward plan). Management held guidance but didn't volunteer pain points; tone defensive, not dismissive.
Romania profitability — Nisarg Shah, Pkeday Investment Office
DodgedToo premature to give timeline. Evaluating and will update next quarter. Focus is to arrest losses and achieve operating profitability, not net profit yet.
Margin breakdown — Varun Jain, Dolat Capital
PartialMix of both. Brass price (copper/zinc) up 6 months, passed 50% through. Solar lower margin contributed. But better product mix within India Engineering.
H2 guidance conservatism — Harshit Patel, Equirus Securities
AnsweredCautious on China (soft), Romania uncertainty, Q3 seasonally soft historically. But nothing negative implied; just being prudent given headwinds.
Long-term capacity vision — Prasenjit Paul, 129 Wealth Fund
AnsweredFrom long-term view, INR2,500-3,000 Cr consol revenue potential, combination of existing capacity utilization and new greenfield investment. Margin 20% plus sustainable at longer horizon.
Romania EBITDA — Koustav, Paul Asset
DodgedWorking on it. Too early. Challenges in cost structure. Will update quarterly.
Capex split and timing — Aditya, Old Bridge Mutual Fund
AnsweredIndia Advantek ~INR110 Cr, China ~INR100 Cr for expansion; total INR220 Cr over 12-15 months case-by-case. Maintenance capex ~INR25-30 Cr consol/year.
Stamping segment margin — Varun Jain, Dolat Capital
DodgedWe don't share breakdown further. Growth is expected; margins will follow.
China growth recovery — Prolin Nandu, Edelweiss Public Alternatives
PartialModerate 5%-7% growth expected. Improvement when new capacity comes; bigger jump post-commercialization Q3 FY28. Right now steady improvement in sales + new products.
Resourcing project scope — Manish Goyal, ThinkWise Wealth Managers
AnsweredOne project INR70-75 Cr annual revenue at peak. Cages side components INR20-30 Cr; aerospace/defense opportunities small but growing. Commercialization Q3/Q4 FY27.
Bushing market opportunity — Manish Goyal, ThinkWise Wealth Managers
PartialLarge windmill bearings 5-8 MW require many Bushings. We're capturing large share incrementally. 16-megawatt windmill now in supply. Bushing part of larger play, not isolated.
Guidance
FY27 India mid- to high-teens growth
HighH1 actual +22% YoY (India segment); Q3 seasonality noted. Management cautious but on trajectory. Bushing/Stamping 30% growth drivers.
FY27 Consol 10%-12% growth
MediumCurrent +16.3% YoY well above guide; offset by China (1% Q2) and Romania (loss). Management says caution on H2 due to seasonality, headwinds; may miss lower end of range or hit higher.
India EBITDA margin 22% sustainable long-term
MediumQ2 India Engineering EBITDA 23.7% achieved; but consol OPM only 17% due to Solar (9% revenue, lower margin) and new capex interest starting. Guidance 20-22% OPM long-term not yet in sight.
Consol EBITDA margin 17%-18% for Engineering business
MediumManagement stated range in call; aligns with current 17% OPM if Solar/Advantek losses improve. Metal price volatility noted as ongoing headwind (absorption lag).
FY27 Capex ₹50-80 Cr (prior); now INR150+ Cr over 12-15 months
HighAdvantek INR110 Cr, China INR100 Cr; split across multiple years. H1 cumulative INR70+ Cr on track. Incremental borrowing approved; targeting completion by June 2027 milestone.
Risks the call surfaced
Romania loss containment
HighFY26 loss ₹14 Cr; FY27 estimated ₹10-12 Cr by analysts (mgmt didn't quantify). Downsizing strategy deferred; capex absorption & restructuring costs not detailed.
China market softness
MediumQ2 FY27 growth only 1% YoY; management guiding 5-7% forward. Soft demand in sequential basis vs India. INR100 Cr capex expansion in uncertain market adds execution risk.
Margin compression from capex
MediumQ2 OPM 17% vs 20-22% guidance. New capex (INR150+ Cr) will incur interest & depreciation starting Q3 FY27. Near-term PAT pressure before commercialization revenue arrives (Q3/Q4 FY27).
Metal price volatility
MediumBrass prices (copper/zinc) up 6 months; management passing through ~50% to customers. Remaining 50% absorbed, impacting margins. Volatility expected to continue; customer contracts may resist further increases.
Capex execution & commercialization timing
MediumINR150+ Cr capex (Advantek INR110 Cr, China INR100 Cr) targeted 12-15 months completion. Customer approval delays possible; commercialization timeline (Q3/Q4 FY27 for Cage, Q3 FY28 for China) uncertain. Near-term cash burn with deferred revenue uplift.
Resourcing project commercialization risk
LowResourcing/outsourcing project (Europe/US) expected to start commercial sales Q3/Q4 FY27. Peak INR75 Cr run-rate is 12-24 months away. Customer approval delays or volume ramp slower than expected.
Management
Score 6/10. Clear on business color (Cage demand, Bushing ramp, Japan growth), but evasive on sensitive topics. Romania losses deferred; Advantek PAT H1 not volunteered; Stamping margin breakdown withheld. Standard disclosures met; transparency selectively applied. India business on track (+22% H1 YoY, high-teens growth reaffirmed); capex acceleration shows decisiveness (12-15 months vs prior 18 months). Advantek profitability deferred (₹7 Cr H1 loss vs prior positive expectation); missed near-term margin targets (17% OPM vs 20-22%).
1 · Q3/Q4 FY27
Resourcing outsourcing project commercial sales commence; INR75 Cr peak run-rate opportunity
2 · Q3 FY27
China brownfield expansion commences production; adds ~5-7% growth to softened base
3 · H2 FY27
Advantek expansion capacity online; profitability inflection expected; capex ₹110 Cr ongoing
Long-term very optimistic (30% Bushing/Stamping growth, INR75 Cr resourcing, INR150+ Cr capex expansion with renewable/windmill tailwinds), but 12-15 month capex execution and metal price volatility are near-term headwinds.
Growth on Track, but Margins Are Slipping — the Capex Ramp Ahead
Q2 revenue grew 16.3% YoY, validating management's mid-to-high teens India guidance. But operating margin fell to 17%, a full 300 basis points below the 20–22% target. The quarter reveals the near-term cost of the ₹150+ Cr capex expansion underway.
₹440.1 Cr
+16.3% YoY | −3.8% QoQ (seasonal)
17.0%
Target 20–22% | Gap −300 bps
₹45.0 Cr
+23.6% YoY | PAT leverage 10.1%
~+22% YoY
On track for mid-to-high teens FY27
The Q2 result lands like a paradox: top-line growth is running ahead of guidance (+16.3% YoY vs. FY27 guided 10–12% consolidated), yet management is cautious on H2, and margins have compressed hard from target. The reason is operational, not accounting — and it frames the next 12–15 months.
Where the margin went
India's core engineering business is robust: EBITDA margin 23.7% signals pricing power and volume scale. But the consolidated OPM of 17% reflects three headwinds that management partially disclosed and partially deferred. Solar segment (LSB subsidiary) contributed ₹11.9 Cr revenue at just 6.1% EBITDA margin — a 170 bps drag on blended EBITDA if scaled across the business. Capex interest is starting to flow: the ₹150+ Cr expansion (₹110 Cr Advantek, ₹100 Cr China brownfield) announced this quarter will incur depreciation and finance charges from Q3 FY27 onwards, before revenue uplift arrives (Q3/Q4 for Cage outsourcing, Q3 FY28 for China production). Metal price absorption is the third: brass prices (copper/zinc) rose 6 months; management passed through ~50% to customers, absorbing the rest — a mechanical margin brake that persists as long as volatility does.
Claims on the call vs. what holds up
India high-teens growth FY27 reaffirmed
Q2 consolidated +16.3% YoY; India segment ~22% H1 YoY per CFO
Supported
Margin 20–22% sustainable at longer horizon
Q2 OPM 17.0%; India core 23.7% but blended down by Solar/capex drag
Contradicted
Bushing & Stamping each targeting ~30% FY27 growth
Not visible in consolidated; claimed as forward-looking; no segment detail given
Unverified
Advantek guidance ₹140 Cr reaffirmed; PAT positive FY27
H1 loss ₹7 Cr; management now says H2 improvement, not yet positive
Overstated
Consolidated 10–12% FY27 guidance maintained
Q2 delivery +16.3% YoY — well above range; management cautious on H2 (China soft, Romania drag, seasonality)
On track, but caveats
What changed on this call
Capex accelerated: ₹50–80 Cr FY27 → ₹150+ Cr over 12–15 months (₹110 Cr Advantek, ₹100 Cr China brownfield; new capex interest burden starting Q3
Advantek PAT timing deferred: Prior call implied FY27 positive; now H2 inflection only. H1 loss ₹7 Cr vs prior zero expectation
Romania loss now flagged: Was vague prior; management now saying FY27 loss will be 'much lower' than FY26's ₹14 Cr, but didn't quantify. Analyst estimate ₹10–12 Cr
India growth reaffirmed: Mid-to-high teens; +22% H1 YoY (India segment) claimed vs prior 'high-teens' target. On track, not raised
New catalysts disclosed: Resourcing/outsourcing project (Europe/US) ₹75 Cr peak annual run-rate, commercial start Q3/Q4 FY27; Japan customer +28% H1 (windmill gearbox tailwind); large windmill bearing (16 MW) now in supply
The bull-bear ledger
India business validating mid-to-high teens growth reaffirmed; +22% H1 YoY execution strong
Japan customer +28% H1; windmill gearbox market (5–10 MW turbines globally) a structural tailwind
Bushing & Stamping new products launching; Bushing targeting INR 300 Cr (4-year), Stamping INR 150–200 Cr — both from strong demand bases
Resourcing outsourcing project (₹75 Cr peak) de-risks international revenue diversification; commercial start Q3/Q4
Working capital improving (135 days vs 139 days PY); cash generation supporting capex outflows
Q2 OPM 17% vs 20–22% target is a material miss; near-term margin recovery unclear
Solar segment drag (6.1% margin, 9% of revenue) and Advantek loss (₹7 Cr H1) weighing on consolidated EBITDA
Romania ₹10–12 Cr FY27 loss estimated (vs ₹14 Cr FY26); downsizing plan vague; contingent 1–2 quarters
China soft at 1% Q2 YoY; ₹100 Cr capex expansion in uncertain market is execution risk
Metal price absorption (50% pass-through, 50% absorbed) is margin headwind with no visibility to relief
Capex interest & depreciation burden starting Q3; near-term PAT pressure before commercialization revenue (Q3/Q4 FY27 for Cage, Q3 FY28 for China)
Management tone cautious on H2; guided consolidated 10–12% FY27 with caveats on seasonality, Romania, China softness — implies downside risk
How the street is positioned
Harsha closed 2026-11-05 at ₹468.45, up +49.52% from its 52-week low of ₹313.3 but still −23.69% below its all-time high of ₹613.85. The stock trades above its 20-day (₹435.55), 50-day (₹445.73), and 200-day (₹405.8) moving averages — a textbook bullish alignment — yet the drawdown from ATH and rising volume suggest selective conviction, not broad FOMO. RSI 61.3 indicates neutral momentum (not overbought; not oversold).
Institutional flows are mixed. FII ownership stands at 1.79%, down 58 bps QoQ; DII ownership rose to 13.02% (+59 bps QoQ), with promoters steady at 75%. The FII trim is telling: international investors are pulling back slightly even as the stock rallies — likely a signal that near-term margin pressure and capex execution risk are giving them pause. DII accumulation suggests domestic mutual funds and insurance are more comfortable holding through the capex ramp, betting on long-term capacity unlocking.
The chart reconciliation: the stock's bullish trend (above all MAs) reflects confidence in the long-term capex narrative — ₹150+ Cr expansion unlocking Bushing/Stamping 30% growth, resourcing ₹75 Cr ramp, renewables tailwind. But the −23.69% drawdown from ATH and FII trimming signal the market is pricing in 12–15 months of execution risk, margin pressure, and China/Romania uncertainty before the payoff arrives. This is not a "growth at any price" momentum play; it is a disciplined long-term bet with caution on the near-term.
Ranked risks for a holder
Romania loss containment & restructuring clarity
HighFY26 loss ₹14 Cr; FY27 estimated ₹10–12 Cr (mgmt deferred quantification). Downsizing scope and profitability timeline vague. If loss widens or restructuring costs materialize, PAT drag accelerates. Mgmt promised Q3 update; if delayed or unsatisfactory, confidence erodes.
Capex execution & commercialization timing
High₹150+ Cr capex (₹110 Cr Advantek, ₹100 Cr China) over 12–15 months is aggressive. Customer approval delays possible; commercialization revenue (Q3/Q4 for Cage, Q3 FY28 for China) uncertain. Near-term cash burn before revenue uplift; if timeline slips or ramp is slower, ROIC and PAT recovery delayed.
Margin recovery trajectory unclear
HighQ2 OPM 17% vs 20–22% target is not a seasonal dip but structural. Solar drag, capex interest, metal absorption are persistent. If Q3/Q4 OPM stays ≤17%, or if capex interest further compresses to 16%, margin recovery thesis breaks. This is the number to track next quarter.
China market softness & capex risk
MediumChina Q2 growth only 1% YoY; soft demand signals execution risk. ₹100 Cr capex expansion in uncertain market. If China growth doesn't recover to 5–7% forward guidance, capex ROI compressed and timeline becomes a liability.
Metal price volatility & pass-through lag
Medium50% absorption mechanism is a margin drain. If brass prices stay elevated or customer contracts resist further increases, margin recovery blocked. This is a macro headwind outside management control but visible in P&L.
Resourcing project commercialization & ramp risk
Low₹75 Cr peak annual run-rate is aspirational; commercial start Q3/Q4 FY27 but ramp to peak is 12–24 months away. If customer approvals delay or volume uptake slower, revenue contribution deferred. But multiple projects in pipeline reduce single-project risk.
What to watch next
1 · Operating margin trajectory in Q3 FY27
Will OPM stay ≤17% or recover toward 18–19%? This is the linchpin: capex interest/depreciation will start flowing; Solar drag will persist. If Q3 OPM is 16% or below, margin recovery thesis is at risk. Track: India EBITDA margin sustainability, Solar profitability, capex interest quantum in P&L.
2 · Romania downsizing scope & profitability timeline
Management promised Q3 clarity on restructuring plan and FY27 loss quantum. If deferred again or loss estimate widens, confidence erodes. If concrete plan emerges (headcount reduction, capacity rationalization timeline), near-term pain is visible but manageable.
3 · Resourcing project commercial traction
Q3/Q4 FY27 commercial sales start. Early revenue visibility and ramp trajectory will validate (or deflate) the ₹75 Cr peak run-rate claim and de-risk the international diversification story.
4 · China capex execution pace & volume pipeline
Is ₹100 Cr brownfield capex on track for Q3 FY28 production start? Any customer order visibility for 5–7% growth forward guidance? Soft Q2 (1%) needs evidence that recovery is coming.
5 · Bushing & Stamping segment growth delivery
Management targets 30% FY27 growth each; Q2 aggregate performance (Bushing +26% QoQ, Stamping +35% YoY) shows momentum. But is this on pace for full-year 30%, or is guidance inflation? Quarterly tracking will clarify.
6 · Advantek profitability inflection in H2
H1 loss ₹7 Cr; management expects H2 improvement and full-year PAT positive. Q3 result will signal whether the ramp is real or another timing miss.
The number to track from here
Operating Profit Margin (OPM). At 17%, it is 300 basis points below the 20–22% guidance. Recovery to 19–20% signals that capex/Solar drag is beginning to fade and that consolidated gross margin is improving. If OPM compresses further in Q3 (guidance 16% or below), the near-term margin-pressure thesis dominates, and re-rating downward becomes inevitable. If OPM expands back to 18.5%+ by Q4, the long-term capex thesis survives and holds credibility.
Harsha is a story of execution unfolding in two speeds: near-term (Q3–Q4 FY27) is a margin-pressure, capex-ramp quarter; long-term (FY28+) is a capacity-expansion, 30%+ growth, renewables-tailwind narrative. The result validates growth (India +22% H1, reaffirmed mid-to-high teens FY27) but challenges margins (OPM 17% vs. 20–22% target). Management has shown decisiveness on capex acceleration and transparency on India segment, but tone is cautious and credibility is slightly dented on Advantek profitability and Romania loss timing.
The market's position (stock above all moving averages, but −23.69% from ATH, FII trimming) reflects this duality: bullish on the long-term, cautious on the near-term. For holders, this is a Hold pending Q3 capex/margin clarity. For fresh entry, wait for better prices (₹430–440) or Q3 evidence that margin recovery is real. The thesis survives — but the near-term is not free. Watch the OPM.
Harsha Q2FY27: consol. PAT +24% YoY on margin jump to 18.6%; India growth lags guidance
PAT +23.57% YoY · revenue +16.32% · margins expanding
₹440.09 Cr
+16.32% YoY
₹45.03 Cr
+23.57% YoY
10.07%
+0.7pp YoY
₹4.95
Harsha Engineers' consolidated Q2 FY27 revenue rose 16.3% YoY to ₹440.09 Cr (down 3.8% sequentially from Q1's ₹457.43 Cr) while consolidated PAT grew faster, up 23.6% YoY to ₹45.03 Cr (+20.5% QoQ from ₹37.38 Cr) — profit outpacing revenue on both comparisons, the primary YoY signal for the quarter. No prior street/consensus estimate specific to this quarter could be found (a pre-result preview explicitly declined to forecast a number for Q2), so the print cannot be graded against a formal consensus; it is graded here against management's own FY27 outlook instead.
Q2 FY-2027 vs prior quarters
The margin story is the real driver: consolidated OPM expanded to 18.6% from 14.1% a year ago and 14.75% last quarter, and NPM rose to 10.23% from 9.37% YoY, as cost pass-throughs caught up with the raw-material inflation and ramp-up costs that had squeezed Q1. That still sits below the 20-22% "sustainable" margin band management guided on the last concall (cross-checked via a PL Capital research note), so this is a recovery toward the target, not an arrival at it.
The stock went into the print at ₹440, down 7.3% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters.
What the summary numbers don't show
Basic consolidated EPS ₹4.95 vs ₹4.00 YoY and ₹4.11 QoQ
FY27: India high-teens growth (upgraded from mid-teens), consolidated low-to-medium teens. Bushing/Stamping each ~30% growth; Advantek ₹140 Cr; margin 20-22% sustainable. CapEx ₹50-80 Cr FY27.
— This quarter: met
Growth itself was uneven beneath the consolidated headline. Standalone (effectively the India entity) revenue grew just 8.5% YoY to ₹302.47 Cr — well short of management's "high-teens" India growth guidance and PL Capital's ~15% India-engineering estimate — while the subsidiaries (China, Europe/Romania, Advantek) collectively grew revenue roughly 38% YoY to make up the consolidated gap. But that faster-growing subsidiary book is currently a profitability drag, not a contributor: standalone PAT of ₹49.36 Cr alone exceeds the group's ₹45.03 Cr, consistent with analyst commentary flagging Romania losses and Advantek still ramping toward a targeted FY27-end breakeven. No company press release was available to cross-check management's own framing of the quarter. Corporate developments on file this quarter (two management departures, trading-window closure ahead of results) are routine governance items unconnected to the print.
W1
Whether OPM keeps closing the gap to the guided 20-22% sustainable band from 18.6% this quarter
W2
Whether India/standalone revenue growth accelerates toward the guided 'high-teens' pace from 8.5% YoY this quarter
W3
Advantek's progress toward its targeted FY27-end breakeven, given subsidiary losses are currently pulling consolidated PAT below standalone PAT
Clean digital filing, unambiguous column headers, both statements tie out exactly; no exceptional-item line in either P&L (consol. PBT includes ₹0.13 Cr JV profit share); standalone PAT (₹49.36 Cr) exceeds consolidated (₹45.03 Cr) because overseas subsidiaries are a net drag (China sub alone posted a ₹1.68 Cr net loss this quarter per auditor note).